kras mutation and glutathion KRAS-Mutant Lung Cancer: Targeting Molecular Immunologic Pathways, Therapeutic Advantages and Restrictions KRAS mutation shown to promote
KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy Frontiers Targeting KRAS: The Elephant in the Room of Epithelial Cancers Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell
Pay in 4 interest-free payments of $5.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19



